Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case

Cover Page

Abstract


Objectives. The relationship between the development of the number of malignant tumors in children and viruses is well known. The etiological role of the Epstein–Barr virus in the development of undifferentiated nasopharyngeal cancer (NPC) has been well studied. The effect of human papillomavirus (HPV) on the occurrence and development of NPC in children is not sufficiently understood.

Aim. The description of the clinical case of the Epstein Barr virus and HPV infection in 16-year-old patient with the consistent development of NPC and oropharyngeal papillomatosis.

Description of the clinical case. The clinical observation of the boy who was diagnosed with NPC. The full clinical effect in the form of reduction of the primary tumor and metastases in the lymph nodes of the neck was noted after chemo- and radiotherapy. 18 months after the cure according to the positron emission tomography, combined with computed tomography, with 18F-deoxyglucose we marked the accumulation of radiopharmaceuticals in the area of the left palatine and lingual tonsils. The examination revealed clinical signs of the soft palate papillomatosis. The resection of the soft palate was carried out. The morphological study confirmed squamous cell papilloma. HPV type 16 DNA was found in the papilloma.

Conclusion. The accumulation of the information concerning childhood pharynx lesions caused by HPV would help to expand understanding of the most common types of the virus in the paediatric population. It would be possible to identify the groups of risk for the development of malignant tumors on the grounds of the detection HPV types of highly carcinogenic risk.


Full Text

Restricted Access

About the authors

Tatiana V. Gorbunova

Blokhin National Medical Research Center of Oncology

Author for correspondence.
Email: wasicsol@mail.ru
ORCID iD: 0000-0001-5805-726X

Russian Federation, Moscow

Cand. Sci. (Med.)

Elena Iu. Radtsig

Pirogov Russian National Research Medical University

Email: radtsig_e@rsmu.ru
ORCID iD: 0000-0003-4613-922X

Russian Federation, Moscow

D. Sci. (Med.), Prof.

Oleg A. Merkulov

Blokhin National Medical Research Center of Oncology

Email: 9166718244@mail.ru
ORCID iD: 0000-0002-8533-0724

Russian Federation, Moscow

Cand. Sci. (Med.)

Mikhail R. Bogomil’skii

Pirogov Russian National Research Medical University

Email: 9166718244@mail.ru

Russian Federation, Moscow

D. Sci. (Med.), Prof., Acad. RAS

Vladimir G. Poliakov

Blokhin National Medical Research Center of Oncology

Email: vgp-04@mail.ru
ORCID iD: 0000-0002-8096-0874

Russian Federation, Moscow

D. Sci. (Med.), Prof., Acad. RAS

References

  1. Syrjänen S. Current concepts on human papillomavirus infections in children APMIS 2010; 118 (6–7): 494–509. doi: 10.1111/j.1600-0463.2010.02620.x
  2. Wojtera M, Paradis J, Husein M et al. The prevalence of human papillomavirus in pediatric tonsils: a systematic review of the literature. J Otolaryngol Head Neck Surg 2018 30; 47 (1): 8. doi: 10.1186/s40463-018-0255-1
  3. Syrjänen K, Syrjänen S, Lamberg M et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983; 12 (6): 188–96.
  4. Testi D, Nardone M, Melone P et al. HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions Oral Implantol (Rome) 2015; 8 (2–3): 45–51. doi: 10.11138/orl/2015.8.2.045
  5. Moore P, Chang Y. Why do viruses cause cancer? Higlights of the first century of human tumor virology. Nat Rev Cancer. 2010; 10: 878–89.
  6. Scheffner M, Werness B, Huibregtse J et al. The E6 oncoprotein encoded by human papillomavirus 16 and 18 promotes the degradation of p53. Cell 1990; 21: 1129–36.
  7. Klaes R, Woerner S, Ridder R, Wentzense N et al. Detection of high-risk cervical interaepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1990; 59: 6132–6.
  8. Zur Hausen H. Papillomavirus and cancer: from basicstudies to clinical application. Nat Rev Cancer 2002; 2: 342–50.
  9. Erdman J. Recent studies/attempt to clarify relationship between oral cancer and human papillomavirus. J Nat Cancer Inst 2003; 95: 638–9.
  10. Nair S, Pillai M. Human papillomavirus and disease mechanisms: relevance to oral and cervical cancer. Oral Dis 2005; 11: 350–9.
  11. Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis 2006; 1: 23.
  12. Lu S, Chang H, Sun X et al. Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents. Medicine (Baltimore) 2016; 95 (17): e3445.
  13. Chan J. Virus-associated neoplasms of the nasopharynx and sinonasal trac: diagnostic problems. Modern Pathology 2017; 30: 568–83.
  14. Vaughan TL, Shapiro JA, Burt RD et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996; 5 (8): 587–93.
  15. Rodriguez-Galindo C, Wofford M, Castleberry RP et al. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 2005; 103 (4): 850–7.
  16. Stenmarc M, McHugh JB, Schipper M et al. Nonendemic HPV-Positive Nasopharingeal Carcinoma: association with poor prognosis Int J Radiat Oncol Biol Phys 2014; 88 (3): 580–8.
  17. Bouvard V, Baan R, Straif K et al; A review of human carcinogens. Part B: biological agents. WHO International Agency for Research on Cancer Monograph Working Group. Lancet Oncol 2009; 10 (4): 321–2.
  18. St Guily JL, Jacquard AC, Prétet JL et al. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France – The EDiTH VI study. J Clin Virol 2011; 51 (2): 100–4. doi: 10.1016/j.jcv.2011.03.003
  19. Siriwardena BS, Tilakaratne A, Amaratunga EA et al. Demographic, etiological and survival differences of oral squamous cell carcinoma in the young and the old ni Sri Lanka. Oral Oncol 2006; 42: 831–6.
  20. Udeabor S, Rana M, Wegener G et al. Squamous cell carcinoma of the oral cavity and the oropharynx in patients lee than 40 years of age: a 20-year analysis. Head and Neck Oncology 2012; 4: 28–34.
  21. Syrjänen S, Puranen M. Human papillomavirus infections in children: the potential role of maternal transmission. Crit Rev Oral Biol Med 2000; 11 (2): 259–74.
  22. Бойко Н.В., Панченко С.Н. Обнаружение вируса папилломы человека при гиперпластических процессах в ЛОР-органах. Вестн. оториноларингологии. 2017; 2: 51–4. [Boiko N.V., Panchenko S.N. Obnaruzhenie virusa papillomy cheloveka pri giperplasticheskikh protsessakh v LOR-organakh. Vestn. otorinolaringologii. 2017; 2: 51–4 (in Russian).]
  23. Tamura S, Yamazaki A, Kunimoto M et al. Impaired Long-Term T-cell Immuniti to Epstein-Barr Virus in Patients With Nasopharyngeal Carcinoma. Jpn J Cancer Res 1992; 83 (5): 445–9.
  24. Lo E, Bell D, Woo J et al. Human papillomavirius and who type I nasopharyngeal carcinoma. Laryngoscope 2010; 120: 1990–7.
  25. Maxwell J, Kumar B, Feng F et al. Hpv-positive/p16-positive/ebv-negative nasopharyngeal carcinoma in white north americans. Head Neck 2010; 32: 562–7. doi: 10.1002/hed.21216
  26. Lin Z, Khong B, Kwok S et al. Human papillomavirus16 detected in nasopharyngeal carcinomas in Caucasian americans but not in endemic southern Chinese patients. Head Neck 2013.
  27. Ruuskanen M, Irjala H, Minn H et al. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: a nationwide study in Finland. Head Neck 2019; 41: 349–57.
  28. Švajdler M Jr, Mezencev R, Kašpírková J et al. Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen’s disease. Diagn Pathol 2016; 11 (1): 53.
  29. Cheuk DK, Billups CA, Martin MG et al. Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer 2011; 117 (1): 197–206. doi: 10.1002/cncr.25376
  30. Huh WK, Joura EA, Giuliano AR et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017; 390 (10108): 2143–59. doi: 10.1016/S0140-6736 (17)31821-4
  31. Bergman H, Buckley BS, Villanueva G et al. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database Syst Rev 2019; 2019 (11).

Supplementary files

Supplementary Files Action
1.
Fig. 1: a – the arrow shows pathological tissues in the nasopharynx, blocking the lumen, involving the palatine tonsils, heterogeneous accumulating contrast drug; b – the arrow shows almost complete narrowing of the nasopharynx lumen.

Download (467KB) Indexing metadata
2.
Fig. 2. The arrow indicates the tumor that occupies the nasopharynx and prolapses into the choana.

Download (358KB) Indexing metadata
3.
Fig. 3: a – the arrow shows the nasopharyngeal vault with the presence of indecipherable additional tissues; b – the arrow shows the clear lumen of the nasopharynx.

Download (323KB) Indexing metadata
4.
Fig. 4. Multiple papillomas of the soft palate.

Download (257KB) Indexing metadata

Statistics

Views

Abstract - 11

PDF (Russian) - 0

Cited-By


PlumX

Dimensions

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies